Cas:99441-47-1 2-(2-methylpropoxy)ethyl 2-(2-cyanoethylamino)-5-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzoate manufacturer & supplier

We serve Chemical Name:2-(2-methylpropoxy)ethyl 2-(2-cyanoethylamino)-5-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzoate CAS:99441-47-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(2-methylpropoxy)ethyl 2-(2-cyanoethylamino)-5-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzoate

Chemical Name:2-(2-methylpropoxy)ethyl 2-(2-cyanoethylamino)-5-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzoate
CAS.NO:99441-47-1
Synonyms:2-isobutoxyethyl-2-(2-cyanoethylamino)-5-(5-nitro-1,3-thiazol-2-ylazo)benzoate
Molecular Formula:C19H22N6O5S
Molecular Weight:446.48000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:183.02000
Exact Mass:446.13700
LogP:5.21788

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-isobutoxyethyl-2-(2-cyanoethylamino)-5-(5-nitro-1,3-thiazol-2-ylazo)benzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-isobutoxyethyl-2-(2-cyanoethylamino)-5-(5-nitro-1,3-thiazol-2-ylazo)benzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-isobutoxyethyl-2-(2-cyanoethylamino)-5-(5-nitro-1,3-thiazol-2-ylazo)benzoate Use and application,2-isobutoxyethyl-2-(2-cyanoethylamino)-5-(5-nitro-1,3-thiazol-2-ylazo)benzoate technical grade,usp/ep/jp grade.


Related News: Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days. 2-(2-methylpropoxy)ethyl 2-(2-cyanoethylamino)-5-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzoate manufacturer This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 2-(2-methylpropoxy)ethyl 2-(2-cyanoethylamino)-5-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzoate supplier A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns. 2-(2-methylpropoxy)ethyl 2-(2-cyanoethylamino)-5-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzoate vendor A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns. 2-(2-methylpropoxy)ethyl 2-(2-cyanoethylamino)-5-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzoate factory A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns.